The other week, the Acorn team attended the National Women’s Show in downtown Toronto. A health tech company like ours that’s revolutionizing the way we collect stem cells through non-invasive means may not seem like the type of organization you’d expect to see at a show like this. But it was a no-brainer decision for us to attend.
For starters, we can’t stress enough that banking your stem cells at a young age is far more beneficial than banking them when you’re older. Our cells age, just as we age, making them a poor therapeutic resource. And as science innovates with advancements in stem cell therapies and genetics, in our lifetime we will see some of the biggest healthcare challenges of our generation solved with our own cells. Preparing for that future precision medicine means locking in your cells at their youngest and most viable.
Until recently, umbilical cord stem cell banking had really been the only method for capturing these cells at the youngest age possible, but the procedure is complex and incredibly expensive. It was financially out of reach for most people wanting to bank their child’s cells. Only a very small percentage of those who could bank their child’s umbilical cord actually do.
With Acorn, our stem cell collection is done by simply plucking a few hair follicles from a person’s head – making stem cell collection accessible for everyone – not just at birth! That provides families with the option to bank their child’s cells at a young age without all the traditional complexities of umbilical cord banking. So from a marketing perspective, it made complete sense for Acorn to attend the women’s show and tell our story to women who are often the major decision-maker in a family when it comes to healthcare. We explained to them how big a role regenerative medicine will play in the future of healthcare, and that now is the right time to prepare for it.
As a mother myself, I personally believe that banking stem cells will quickly become as important as saving for an RRSP in terms of my long-term well-being; and that banking my child’s stem cells will be as important as opening up an RESP for them. Parents want the best for their kids, and as stem cell therapy treatments become more mainstream in the years to come, banking their cells could be potentially life-saving.
In fact, the global stem cell therapy industry is worth tens of billions of dollars, and governments around the world, including Canada’s, are taking proactive steps to ensure the safety and efficacy of these procedures. They’re making sure stem cell therapies adhere to the highest standards, and that patient safety is always paramount.
At Acorn, we’re far past the point of asking if regenerative medicine will be a dominant force in healthcare; we’re determining when. And so that’s why I believe it’s never too early to educate parents or those contemplating parenthood on the benefits of stem cell collection over the long term. It’s a biological insurance policy that will deliver access to leading medical care that none of us want to miss out on — especially if it can improve the lives of our kids.